Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Clinical and Translational Radiation Oncology|January 6, 2022
A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescenceEloïse Baudou, Jérémie Pariente, Patrice Péran, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 22, 2015
Long-term side effects of radiotherapy for pediatric localized neuroblastoma : results from clinical trials NB90 and NB94Anne Ducassou, Marion Gambart, Caroline Munzer, et al.
International Journal of Radiation Oncology, Biology, Physics|August 14, 2018
Pediatric Localized Intracranial Ependymomas: A Multicenter Analysis of the Société Française de lutte contre les Cancers de l'Enfant (SFCE) from 2000 to 2013Anne Ducassou, Laetitia Padovani, Leonor Chaltiel, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 30, 2023
PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG studyAlejandra Martinez, Fabrice Lecuru, Nicolò Bizzarri, et al.
The Lancet. Oncology|November 3, 2023
A CT-based radiomics classification model for the prediction of histological type and tumour grade in retroperitoneal sarcoma (RADSARC-R): a retrospective multicohort analysisAmani Arthur, Matthew R Orton, Robby Emsley, et al.
Journal of Medical Economics|June 23, 2026
Economic evaluation of adjuvant chemotherapy for non-metastatic sarcoma using the real-world data from the French nationwide DEEPSARC studyLionel Perrier, Magali Morelle, Sylvie Bonvalot, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2022
Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue SarcomaSylvie Bonvalot, Piotr L Rutkowski, Juliette Thariat, et al.
The Lancet. Oncology|July 13, 2019
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trialSylvie Bonvalot, Piotr L Rutkowski, Juliette Thariat, et al.
The Lancet Regional Health. Europe|August 13, 2025
Clinical presentation, management and outcome of 11,132 patients with liposarcoma patients: a population-based study from the NETSARC+ registryJean-Yves Blay, Maud Toulmonde, Thibaud Valentin, et al.
Pageof 6